| 1 |
Yao JC,Hassan M,Phan A, et al. One hundred years after'carcinoid’：epidemiology of and prognostic factors for neuroendocrine tumors in 35, 825 cases in the United States[J]. J Clin Oncol, 2008, 26(18): 3063-3072.
|
| 2 |
Lawrence B,Gustafsson BI,Chan A, et al. The epidemiology of gastroenteropancreatic neuroendocrine tumors[J]. Endocrinol Metab Clin North Am, 2011, 40(1): 1-18.
|
| 3 |
Ito T,Sasano H,Tanaka M, et al. Epidemiological study of gastroenteropancreatic neuroendocrine tumors in Japan[J]. J Gastroenterol, 2010, 45(2): 234-243.
|
| 4 |
Modlin IM,Oberg K,Chung DC, et al. Gastroenteropancreatic neuroendocrine tumors[J]. Lancet Oncol, 2008, 9(1): 61-72.
|
| 5 |
Rindi G,Arnold R,Bosman FT, et al. Nomenclature and classification of neuroendocrine neoplasms of the digestive system//Bosman FT, Carneiro F, Hruban RH, et al. WHO Classification of Tumours of the Digestive System[M]. Lyon: IARC Press, 2010: 13-14.
|
| 6 |
Plockinger U,Wiedenmann B,de Herder WW. ENETS consensus guidelines for the standard of care in neuroendocrine tumors[J]. Neuroendocrinology, 2009, 90(2): 159-161.
|
| 7 |
CSCO神经内分泌肿瘤专家委员会. 中国胃肠胰神经内分泌肿瘤专家共识[J]. 临床肿瘤学杂志, 2013, 18(9): 815-832.
|
| 8 |
Mansour JC,Chen H. Pancreatic endocrine tumors[J]. J Surg Res, 2004, 120(1): 139-161.
|
| 9 |
杨军,周光文. 手术切除治疗胰腺神经内分泌肿瘤肝转移的META分析[J]. 中华内分泌外科杂志, 2013, 7(5): 418-423.
|
| 10 |
Gedaly R,Daily MF,Davenport D, et al. Liver transplantation for the treatment of liver metastases from neuroendocrine tumours-an analysis of the UNOS database[J]. Arch Surg, 2011, 146(8): 953-958.
|
| 11 |
Frilling A,Al-Nahhas A,Clift AK. Transplantation and debulking procedures for neuroendocrine tumors[J]. Front Horm Res, 2015, 44: 164-176.
|
| 12 |
Partelli S,Inama M,Rinke A, et al. Long-term outcomes of surgical management of pancreatic neuroendocrine tumors with synchronous liver metastases[J]. Neuroendocrinology, 2015, 102(1-2): 68-76.
|
| 13 |
Engelman ES,Leon-Ferre R,Naraev BG, et al. Comparison of transarterial liver-directed therapies for low-grade metastatic neuroendocrine tumors in a single institution[J]. Pancreas, 2014, 43(2): 219-225.
|
| 14 |
中华医学会肿瘤学分会胰腺癌学组. 胰腺神经内分泌肿瘤诊治专家共识[J]. 中华肿瘤杂志, 2014, 36(9): 717-720.
|
| 15 |
Raymond E,Dahan L,Raoul JL, et al. Sunitinib malate for the treatment of pancreatic neuroendocrine tumors[J]. N Engl J Med, 2011, 364(6): 501-513.
|
| 16 |
Yao JC,Shah MH,Ito T, et al. Everolimus for advanced pancreatic neuroendocrine tumors[J]. N Engl J Med, 2011, 364(6): 514-523.
|
| 17 |
Makowka L,Tzakis AG,Mazzaferro V, et a1.Transplantation of the liver for metastatic endocrine tumors of the intestine and pancreas[J]. Surg Gynecol Obstet, 1989, 168(2): 107-111.
|
| 18 |
Lehnert T. Liver transplantation for metastatic neuroendocrine carcinoma: an analysis of 103 patients[J]. Transplantation, 1998, 66(10): 1307-1312.
|
| 19 |
Rosenau J,Bahr M,von Wasielewski R, et al. Ki-67, E-cadherin, and p53 as prognostic indicators of long-term outcome after liver transplantation for metastatic neuroendocrine tumours[J]. Transplantation, 2002, 73(3): 386-394.
|
| 20 |
Florman S,Toure B,Kim L, et al. Liver transplantation for neuroendocrine tumors[J]. J Gastrointest Surg, 2004, 8(2): 208-212.
|
| 21 |
van Vilsteren FGI,Baskin-Bey ES,Nagorney DM, et al. Liver transplantation for gastroenteropancreatic neuroendocrine cancers; defining selection criteria to improve survival[J]. Liver Transpl, 2006, 12(3): 448-456.
|
| 22 |
Olausson M,Friman S,Herlenius G, et al. Orthotopic liver or multivisceral transplantation as treatment of metastatic neuroendocrine tumours[J]. Liver Transpl, 2007, 13(3): 327-333.
|
| 23 |
Frilling A,Malago M,Weber F, et al. Liver transplantation for patients with metastatic endocrine tumours: single-center experience with 15 patients[J]. Liver Transpl, 2006, 12(7): 1089-1096.
|
| 24 |
Mazzaferro V,Pulvirenti A,Coppa J. Neuroendocrine tumours metastatic to the liver: how to select patients for liver transplantation[J]. J Hepatol, 2007, 47(4): 460-466.
|
| 25 |
Mazzaferro V,Sposito C,Coppa J, et al. The Long-term benefit of liver transplantation for hepatic metastases from neuroendocrine tumors[J]. Am J Transplant, 2016, 16(10): 2892-2902.
|
| 26 |
Bonnacorsi-Riani E,Apestegui C,Jouret-Mourin A, et al. Liver transplantation and neuroendocrine tumors: lessons from a single centre experience and from the literature review[J]. Transplant Int, 2010, 23(7): 668-678.
|
| 27 |
Chen Xiaobo,Yang Jie,Xu Mingqing, et al. Liver transplantation for hepatic metastatic pancreatic insulinoma with a survival over five years[J]. Chin Med J (Engl), 2012, 125(15): 2768-2771.
|
| 28 |
Grat M,Remiszewski P,Smoter P, et al. Outcomes following liver transplantation for metastatic neuroendocrine tumors[J]. Transplant Proc, 2014, 46(8): 2766-2769.
|
| 29 |
Yankol Y,Mecit N,Kanmaz T, et al. Living donor liver transplantation: a life-saving option in emergency situations for diffuse hepatic neuroendocrine tumor metastasis[J]. Transplant Proc, 2015, 47(2): 427-430.
|
| 30 |
Le Treut YP,Gregoire E,Belghiti J, et al. Predictors of long-term survival after liver transplantation for metastatic endocrine tumors: an 85-case French multicentric report[J]. Am J Transplant, 2008, 8(6): 1205-1213.
|
| 31 |
Máthé Z,Tagkalos E,Paul A, et al. Liver Transplantation for hepatic metastases of neuroendocrine pancreatic tumors: a survival-based analysis[J]. Transplantation, 2011, 91(5): 575-582.
|
| 32 |
Nguyen NT,Harring TR,Goss JA, et al. Neuroendocrine liver metastases and orthotopic liver transplantation: the US experience[J]. Int J Hepatol, 2011: 742890.
|
| 33 |
Le Treut YP,Gregoire E,Klempnauer J, et al. Liver transplantation for neuroendocrine tumors in Europe-results and trends in patient selection: a 213-case European liver transplant registry study[J]. Ann Surg, 2013, 257(5): 807-815.
|
| 34 |
Sher LS,Levi DM,Wecsler JS, et al. Liver transplantation for metastatic neuroendocrine tumors: outcomes and prognostic variables[J]. J Surg Oncol, 2015, 112(2): 125-132.
|
| 35 |
Frilling A,Li J,Malamutmann E, et al. Treatment of liver metastases from neuroendocrine tumours in relation to the extent of hepatic disease[J]. Br J Surg, 2009, 96(2): 175-184.
|
| 36 |
Soreide O,Berstad T,Bakka A, et al. Surgical treatment as a principle in patients with advanced abdominal carcinoid tumours[J]. Surgery, 1992, 111(1): 48-54.
|
| 38 |
Fan ST,Le Treut,Mazzaferro V, et al. Liver transplantation for neuroendocrine tumour liver metastases[J]. HPB (Oxford), 2015, 17(1): 23-28.
|
| 39 |
Nobel YR,Goldberg DS. Variable use of model for end-stage liver disease exception points in patients with neuroendocrine tumors metastatic to the liver and its impact on patient outcomes[J]. Transplantation, 2015, 99(11): 2341-2346.
|
| 40 |
Pavel M,Baudin E,Couvelard A, et al. ENETS consensus guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary[J]. Neuroendocrinology, 2012, 95(2): 157-176.
|
| 41 |
Coppa J,Pulvirenti A,Schiavo M, et al. Resection versus transplantation for liver metastases from neuroendocrine tumors[J]. Transplant Proc, 2001, 33(1-2): 1537-1539.
|